<![CDATA[71]]>71
Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL)

This study is not yet open for participant recruitment.

Verified on December 2011 by H. Lee Moffitt Cancer Center and Research Institute

First Received on December 20, 2011.

]]>https://dev.proinvestor.com/forum/topic/448394/71RSS for NodeSat, 20 Jun 2026 00:50:32 GMTThu, 22 Dec 2011 15:42:51 GMT60